A total of 82 of 116 (70.69 %) malignant cases showed positive staining for Tim-3, 18 of 92 (19.57 %) benign cases showed positive, and the difference of Tim-3 expression between PCa and BPH was statistically significant (P < 0.001). The gene discussed is HAVCR2; the disease is posterior cortical atrophy.